Lots of interesting abstracts were submitted from all over the world for TCTAP 2020, and below are strictly selected abstracts after meticulously reviewed by scientific committee.
Total: 106 (9/11 pages)
Abstract No. Category Abstract Title Presenter
Peripheral Vascular Disease and Intervention 3 Year Follow-Up in BIOPAC Trial – Treating Lesions in Femoro-Popliteal Segment Using Microcrystalline and Biocompatible Polymer Paclitaxel Coated Balloon vs. Plain Balloon Angioplasty Przemek Nowakowski Click! if you like it. 0
Vascular Access (transradial) Optical Coherent Tomographic Assessment of Radial Artery After Transradial Coronary Intervention via Distal Radial Access at Anatomical Snuffbox Sang Yeub Lee Click! if you like it. 0
Diabetes Prediabetes and Long-Term Outcomes in Patients with Three-Vessel Disease Deshan Yuan Click! if you like it. 0
Pre-Clinical/First In-Human Studies Suicide Attempts in Patients with Pulmonary Hypertension - Lessons from an Asian Registry of 15454 Study Participants Wei-Syun Hu Click! if you like it. 0
Acute Coronary Syndromes (STEMI, NSTE-ACS) ABO Blood Types and Cardiovascular Mortality in Patients with Myocardial Infarction Chao Wu Click! if you like it. 0
Drug-Eluting Balloons Clinical Efficacy and Safety of Sirolimus Drug Coated Balloon in a Real-World Single-Center Registry of South-East Asian Patients Zin Mar Mar Than Click! if you like it. 0
Physiologic Lesion Assessment Post Procedural Physiological Assessment of CTO Lesion Nao Yasuda Click! if you like it. 1
Bifurcation/Left Main Diseases and Intervention Outcomes of Percutaneous Coronary Intervention of Left Main Coronary Artery Disease in Mongolia Batmyagmar Khuyag Click! if you like it. 1
Acute Coronary Syndromes (STEMI, NSTE-ACS) Apolipoprotein B/A-I Ratio Predicts Lesion Severity and Long-Term Outcomes in Diabetic Patients with Acute Coronary Syndromes Yue Liu Click! if you like it. 0
Drug-Eluting Balloons The Outcome of Cutting Balloon Combined with Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis You-Cheng Zheng Click! if you like it. 0